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We are now halfway through the "Decade of the Brain," an appropriate time to applaud the progress we have made in neurological research and to consider the promise the future holds for additional breakthroughs.
In the past 5 years, we have produced new medications for the treatment of multiple sclerosis, epilepsy, and migraine headaches. We 
